<?xml version="1.0" encoding="utf-8"?>
<DATASETS>
	<DATASET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" alias="LIRI-JP_PCAWG_RNA-Seq_TopHat2" center_name="ICGC" broker_name="EGA" accession="EGAD00001003546">
		<TITLE>ICGC PCAWG Dataset: LIRI-JP_PCAWG_RNA-Seq_TopHat2</TITLE>
		<DESCRIPTION>ICGC PCAWG Dataset for RNA-Seq BAM aligned using TopHat2. Project: LIRI-JP.</DESCRIPTION>
		<ANALYSIS_REF accession="EGAZ00001312245"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312246"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312247"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312248"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312249"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312250"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312251"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312252"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312253"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312254"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312255"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312256"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312257"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312258"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312259"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312260"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312261"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312262"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312263"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312264"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312265"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312266"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312267"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312268"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312269"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312270"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312271"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312272"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312273"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312274"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312275"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312276"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312277"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312278"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312279"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312280"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312281"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312282"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312283"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312284"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312285"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312286"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312287"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312288"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312289"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312290"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312291"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312292"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312293"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312294"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312295"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312296"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312297"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312298"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312299"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312300"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312301"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312302"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312303"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312304"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312305"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312306"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312307"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312308"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312309"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312310"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312311"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312312"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312313"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312314"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312315"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312316"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312317"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312318"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312319"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312320"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312321"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312322"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312323"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312324"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312325"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312326"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312327"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312328"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312329"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312330"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312331"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312332"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312333"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312334"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312335"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312336"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312337"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312338"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312339"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312340"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312341"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312342"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312343"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312344"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312345"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312346"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312347"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312348"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312349"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312350"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312351"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312352"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312353"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312354"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312355"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312356"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312357"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312358"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312359"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312360"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312361"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312362"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312363"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312364"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312365"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312366"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312367"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312368"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312369"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312370"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312371"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312372"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312373"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001312374"></ANALYSIS_REF>
		<POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
			<IDENTIFIERS>
				<PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
				<SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
			</IDENTIFIERS>
		</POLICY_REF>
		<DATASET_LINKS>
			<DATASET_LINK>
				<URL_LINK>
					<LABEL>ICGC Data Portal</LABEL>
					<URL>http://dcc.icgc.org</URL>
				</URL_LINK>
			</DATASET_LINK>
		</DATASET_LINKS>
	</DATASET>
</DATASETS>